Showing 1-10 of about 11 articles.
Nokia Oyj
Press Release Nokia and Innventure collaborate to innovate and scale disruptive technologies Collaboration begins with disruptive satellite communication technology originating from Nokia...
Nokia Oyj
Press Release Nokia announces over 2,000 5G patent declarations Nokia has declared more than 2,000 5G patent families as essential for 5G, one year after making its first declarations for the...
Worlds Inc.
BOSTON, March 12, 2018 (GLOBE NEWSWIRE) -- Worlds Inc.’s (OTCQB:WDDD) oral argument in its appeal of three Inter Partes Review (IPR) decisions issued in 2016 from the U.S. Patent & Trademark...
Worlds Inc.
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) announced that on January 22, 2018, the United States Court of Appeals for the Federal Circuit scheduled the oral argument for...
Voip-Pal.Com Inc.
BELLEVUE, Wash., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas Sawyer,...
Voip-Pal.Com Inc.
BELLEVUE, Wash., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB:VPLM) is pleased to announce that final decisions in the two Apple IPRs, IPR2016-01201 and...
Voip-Pal.Com Inc.
BELLEVUE, Wash., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas...
The John Marshall Law School-Chicago
CHICAGO, Feb. 4, 2016 (GLOBE NEWSWIRE) -- How are viral videos and other social media phenomena treated under copyright, false endorsement and right of publicity law? What are the best practices for...
GeneriCo, LLC
ST. LOUIS, Dec. 15, 2015 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”) today announced that it has recently filed a petition for Inter Partes Review (“IPR”) of United States Patent No. 8,865,688...
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
Showing 1-10 of about 11 articles.
